-Third Subject Safely Treated with the Low-Dose of BB-301 in October 2024, and Fourth Subject Expected to Receive Treatment with the Low-Dose of BB-301 in December 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback